• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE VIABAHN ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number JHJR071002J
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Stenosis (2263)
Event Date 06/01/2019
Event Type  Injury  
Manufacturer Narrative
Additional manufacturer narrative: cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following information was reported: this patient is a man in his (b)(6).On an unknown date, the patient fell during snowboarding.Three days later, swelling and pain in the right shoulder got worse, and the patient was referred to the hospital.Computed tomography angiography (cta) was performed, and pseudoaneurysm and arteriovenous fistula in the distal portion of the right axillary artery was suspected.The patient was in poor general condition due to bleeding, and had disseminated intravascular coagulation (dic), so it was elected to utilize gore® viabahn® endoprosthesis with heparin bioactive surface (viabahn device).A micro guidewire was inserted from the right upper arm and a snare system was inserted from the right common iliac artery to apply pull-through technique.The viabahn device was implanted in the target lesion with no reported issue.Three days after the procedure, cta confirmed that the pseudoaneurysm and the arteriovenous fistula were disappeared.The patient discharged from the hospital seven days after the procedure.After the procedure, the patient was monitored with dual antiplatelet therapy (dapt).Four months after the procedure, computed tomography showed a middle stenosis around proximal portion of the viabahn device and mild stenosis located distal to the first stenosis region.However, at that time, contrast effect remained in its distal area.(reported previously under mfr report # 2017233-2019-01082) two years after the procedure, the patient underwent a re-intervention using a cutting balloon (6 mm/2 cm) and a non-compliant high pressure balloon (7 mm/4 cm) for the stenosis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
heidi inskeep
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12177671
MDR Text Key263374037
Report Number2017233-2021-02175
Device Sequence Number1
Product Code NIP
Combination Product (y/n)Y
Reporter Country CodeJA
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,litera
Reporter Occupation Physician
Type of Report Initial
Report Date 07/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberJHJR071002J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/09/2021
Initial Date FDA Received07/15/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
-
-